Skip to main content
SpringerLink
Log in

Myocardial Infarction

  • Chapter
  • First Online:
Anesthesiology

  • 2334 Accesses

Abstract

Acute coronary syndrome represents a medical and potentially surgical emergency. This chapter starts by introducing the basics of myocardial infarction and expands into various interventional strategies such as drug-eluting stents and balloon angioplasty, in addition to other reperfusion strategies. The perioperative management of antiplatelet therapy after percutaneous coronary interventions is also addressed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gersh BJ, Stone GW, White HD, Holmes DR Jr. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? JAMA. 2005;293:979–86.

    Article  CAS  PubMed  Google Scholar 

  2. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60:1581–98.

    Article  PubMed  Google Scholar 

  3. Keely EC, Hills LD. Primary PCI for myocardial infarction with ST-segment elevation. N Eng J Med. 2007;356:47–54.

    Article  Google Scholar 

  4. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2004;100:588–636.

    Article  Google Scholar 

  5. Ahmed S, Antman EM, Murphy SA, Giugliano RP, Cannon CP, White H, et al. Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials). J Thromb Thrombolysis. 2006;21:119–29.

    Article  CAS  PubMed  Google Scholar 

  6. Thune JJ, Hoefsten DE, Linholm MG, Mortensen LS, Andersen HR, Nielsen TT, et al. Simple risk stratification at admission to identify patients with reduced mortality from primary angioplasty. Circulation. 2005;112:2017–21.

    Article  PubMed  Google Scholar 

  7. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock? N Eng J Med 1999;341:625–34.

    Google Scholar 

  8. Grines CL, Cox DA, Stone GW, Garcia E, Mattos LA, Giambartolomei A, et al. Coronary angioplasty with our without stent implantation for acute myocardial infarction. Stent primary angioplasty in myocardial infarction study Group. N Eng J Med 1999;341:1949–56.

    Google Scholar 

  9. Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Eng J Med. 2002;346:957–66.

    Article  CAS  Google Scholar 

  10. Juliard JM, Himbert D, Folmard JL, Aubry P, Karrillon GJ, Boccara A, et al. Can we provide reperfusion therapy to all unselected patients admitted with acute myocardial infarction? J Am Coll Cardiol. 1997;30:157–64.

    Article  CAS  PubMed  Google Scholar 

  11. Gibson CM, Karha J, Murphy SA, James D, Morrow DA, Cannon CP, et al. Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials. J Am Coll Cardiol. 2003;42:7–16.

    Article  PubMed  Google Scholar 

  12. Fibrinolytic Therapy Trialists (FFT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet. 1994;343:311022.

    Google Scholar 

  13. Smith SC Jr, Feldman TE, Hirshfield JW, Jacobs AK, Kern MJ, King SB, et al. ACC/AHA/SCAI guideline update for percutaneous coronary intervention. Circulation. 2006;113:156–75.

    Article  PubMed  Google Scholar 

  14. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation. 1999;100:1872–8.

    Article  CAS  PubMed  Google Scholar 

  15. Cassese S, Byrne RA, Tada T, Pinieck S, Joner M, Ibrahim T, et al. Incidence and predictors of restenosis after coronary stenting in 10,004 patients with surveillance angiography. Heart. 2014;100:153–9.

    Article  PubMed  Google Scholar 

  16. Chen MS, John JM, Chew DP, Lee DS, Ellis SG, Bhatt DL. Bare metal stent restenosis is not a benign clinical entity. Am Heart J. 2006;151:1260–4.

    Article  PubMed  Google Scholar 

  17. Alfonso F, Byrne RA, Rivero F, Kastrati A. Current treatment of in-stent restenosis. J Am Coll Cardiol. 2014;63:2659–73.

    Article  PubMed  Google Scholar 

  18. Indermuehle A, Bahl R, Lansky AJ, Froehlich GM, Knapp G, Timmis A, et al. Drug-eluting balloon angioplasty for in-stent restenosis: a systematic review and meta-analysis of randomized control trials. Heart. 2013;99:327–33.

    Article  PubMed  Google Scholar 

  19. Dangas GD, Claessen BE, Caixeta A, Sanidas EA, Mintz GS, Mehran R. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol. 2010;56:1897–907.

    Article  PubMed  Google Scholar 

  20. Myat A, Patel N, Tehrani S, Banning AP, Redwood SR, Bhatt DL. Percutaneous circulatory assist devices for high-risk coronary intervention. JACC. 2015;8:229–44.

    PubMed  Google Scholar 

  21. Rihal CS, Naidu SS, Givertz MM, Szeto WY, Burke JA, Kapur NK, et al. 2015 SCA/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care. J Card Fail. 2015;21:499–518.

    Article  PubMed  Google Scholar 

  22. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494–502.

    Article  CAS  PubMed  Google Scholar 

  23. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001;358:527–33.

    Article  CAS  PubMed  Google Scholar 

  24. Steinhubl SR, Berger PB, Mann JT III, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288:2411–20.

    Article  CAS  PubMed  Google Scholar 

  25. Patti G, Colonna G, Pasceri V, Pepe LL, Montinaro A, Di SG. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of Myocardial Damage during Angioplasty) study. Circulation. 2005;111:2099–106.

    Article  CAS  PubMed  Google Scholar 

  26. Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK, et al. Stent anticoagulation restenosis study investigators. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med. 1998;339:1665–71.

    Article  CAS  PubMed  Google Scholar 

  27. Darvish-Kazem S, Gandhi M, Marcucci M, Douketis JD. Perioperative management of antiplatelet therapy in patients with a coronary stent who need noncardiac surgery: a systematic review of clinical practice guidelines. Chest. 2013;144:1848–56.

    Article  CAS  PubMed  Google Scholar 

  28. Abualsaud AO, Eisenberg MJ. Perioperative management of patients with drug-eluting stents. JACC Cardiovasc Interv. 2010;3:131–42.

    Article  PubMed  Google Scholar 

  29. Tsimikas S. Drug-eluting stents and late adverse clinical outcomes lessons learned, lessons awaited. J Am Coll Cardiol. 2006;47:2112–5.

    Article  CAS  PubMed  Google Scholar 

  30. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126–30.

    Article  CAS  PubMed  Google Scholar 

  31. Thiele T, Sümnig A, Hron G, Müller C, Althaus K, Schroeder HW, et al. Platelet transfusion for reversal of dual antiplatelet therapy in patients requiring urgent surgery: a pilot study. J Thromb Haemost. 2012;10:968–71.

    Article  CAS  PubMed  Google Scholar 

  32. Purkayastha S, Athanasiou T, Malinovski V, Tekkis P, Foale R, Casula R, et al. Does clopidogrel affect outcome after coronary artery bypass grafting? A meta-analysis. Heart. 2006;92:531–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Yende S, Wunderink RG. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med. 2001;29:2271–5.

    Article  CAS  PubMed  Google Scholar 

  34. Leong JY, Baker RA, Shah PJ, Cherian VK, Knight JL. Clopidogrel and bleeding after coronary artery bypass graft surgery. Ann Thorac Surg. 2005;80:928–33.

    Article  PubMed  Google Scholar 

  35. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001–15.

    Article  CAS  PubMed  Google Scholar 

  36. Wiviott SD, Trenk D, Frelinger AL, O’Donoghue M, Neumann FJ, Michelson AD, et al. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial. Circulation. 2007;116:2923–32.

    Article  CAS  PubMed  Google Scholar 

  37. Cannon CP, Husted S, Harrington RA, Scirica BM, Emanuelsson H, Peters G, et al. Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial. J Am Coll Cardiol. 2007;50:1844–51.

    Article  CAS  PubMed  Google Scholar 

  38. Storey RF, Husted S, Harrington RA, Heptinstall S, Wilcox RG, et al. Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes. J Am Coll Cardiol. 2007;50:1852–6.

    Article  CAS  PubMed  Google Scholar 

  39. Angiolillo DJ, Capranzano P. Pharmacology of emerging novel platelet inhibitors. Am Heart J. 2008;156:S10–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital, 3737 Chestnut St., Apt 2604, Philadelphia, PA, 19104, USA

    Hanjo Ko

Authors
  1. Hanjo Ko
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hanjo Ko .

Editor information

Editors and Affiliations

  1. Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA

    Linda S. Aglio

  2. Institute for Safety in Ofiice Based Systems, Harvard Medical School, Brigham and Women's Hospital, Boston, Lexington, Massachusetts, USA

    Richard D. Urman

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Ko, H. (2017). Myocardial Infarction. In: Aglio, L., Urman, R. (eds) Anesthesiology. Springer, Cham. https://doi.org/10.1007/978-3-319-50141-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-50141-3_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-50139-0

  • Online ISBN: 978-3-319-50141-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation